Return On Equity of Xeris Biopharma Holdings, Inc. from 31 Dec 2020 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Xeris Biopharma Holdings, Inc. quarterly and annual Return On Equity in % history and change rate from 31 Dec 2020 to 30 Sep 2025.
  • Xeris Biopharma Holdings, Inc. Return On Equity for the quarter ending 30 Sep 2025 was 74%, a 81% decline year-over-year.
  • Xeris Biopharma Holdings, Inc. annual Return On Equity for 2024 was 254%.
  • Xeris Biopharma Holdings, Inc. annual Return On Equity for 2023 was -611%, a 337% decline from 2022.
  • Xeris Biopharma Holdings, Inc. annual Return On Equity for 2022 was -140%, a 55% increase from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Xeris Biopharma Holdings, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 74% -323% -81% 01 Jul 2025 30 Sep 2025
Q2 2025 114% -645% -85% 01 Apr 2025 30 Jun 2025
Q1 2025 160% +16823% 01 Jan 2025 31 Mar 2025
Q4 2024 254% +865% 01 Oct 2024 31 Dec 2024
Q3 2024 397% +664% 01 Jul 2024 30 Sep 2024
Q2 2024 759% +958% 01 Apr 2024 30 Jun 2024
Q1 2024 -16663% -16510% -10837% 01 Jan 2024 31 Mar 2024
Q4 2023 -611% -471% -337% 01 Oct 2023 31 Dec 2023
Q3 2023 -267% -101% -61% 01 Jul 2023 30 Sep 2023
Q2 2023 -199% +9.2% +4.4% 01 Apr 2023 30 Jun 2023
Q1 2023 -152% +112% +42% 01 Jan 2023 31 Mar 2023
Q4 2022 -140% +173% +55% 01 Oct 2022 31 Dec 2022
Q3 2022 -165% +227% +58% 01 Jul 2022 30 Sep 2022
Q2 2022 -208% +90% +30% 01 Apr 2022 30 Jun 2022
Q1 2022 -264% +11% +4% 01 Jan 2022 31 Mar 2022
Q4 2021 -313% +54% +15% 01 Oct 2021 31 Dec 2021
Q3 2021 -393% 01 Jul 2021 30 Sep 2021
Q2 2021 -298% 01 Apr 2021 30 Jun 2021
Q1 2021 -275% 01 Jan 2021 31 Mar 2021
Q4 2020 -366% 01 Oct 2020 31 Dec 2020

Xeris Biopharma Holdings, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 254% +865% 01 Jan 2024 31 Dec 2024
2023 -611% -471% -337% 01 Jan 2023 31 Dec 2023
2022 -140% +173% +55% 01 Jan 2022 31 Dec 2022
2021 -313% +54% +15% 01 Jan 2021 31 Dec 2021
2020 -366% 01 Jan 2020 31 Dec 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.